UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 85 filers reported holding UTAH MED PRODS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,229,200 | +15265.0% | 12,292 | +12838.9% | 0.00% | – |
Q1 2021 | $8,000 | -82.6% | 95 | -82.0% | 0.00% | – |
Q4 2020 | $46,000 | +253.8% | 527 | +233.5% | 0.00% | – |
Q3 2020 | $13,000 | -40.9% | 158 | -41.7% | 0.00% | – |
Q2 2020 | $22,000 | -54.2% | 271 | -38.5% | 0.00% | – |
Q4 2019 | $48,000 | +65.5% | 441 | +44.6% | 0.00% | – |
Q3 2019 | $29,000 | -21.6% | 305 | -21.4% | 0.00% | – |
Q2 2019 | $37,000 | +362.5% | 388 | +312.8% | 0.00% | – |
Q1 2019 | $8,000 | -33.3% | 94 | -33.8% | 0.00% | – |
Q4 2018 | $12,000 | +9.1% | 142 | +20.3% | 0.00% | – |
Q3 2018 | $11,000 | -15.4% | 118 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | +44.4% | 118 | +25.5% | 0.00% | – |
Q1 2018 | $9,000 | +12.5% | 94 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | +100.0% | 94 | +17.5% | 0.00% | – |
Q2 2014 | $4,000 | -83.3% | 80 | -80.5% | 0.00% | – |
Q1 2014 | $24,000 | -44.2% | 411 | -44.8% | 0.00% | – |
Q4 2013 | $43,000 | -2.3% | 744 | 0.0% | 0.00% | – |
Q3 2013 | $44,000 | +10.0% | 744 | 0.0% | 0.00% | – |
Q2 2013 | $40,000 | – | 744 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 40,000 | $4,000,000 | 5.64% |
Clean Yield Group | 14,474 | $1,447,000 | 0.46% |
RICE HALL JAMES & ASSOCIATES, LLC | 113,833 | $11,383,000 | 0.40% |
Ranger Investment Management | 68,730 | $6,873,000 | 0.38% |
ISTHMUS PARTNERS, LLC | 17,534 | $1,753,000 | 0.29% |
Cardinal Capital Management | 10,097 | $1,010,000 | 0.20% |
GLOBEFLEX CAPITAL L P | 19,420 | $1,942,000 | 0.20% |
Ancora Advisors LLC | 26,689 | $2,669,000 | 0.06% |
Penobscot Investment Management Company, Inc. | 4,000 | $400,000 | 0.05% |
SEIZERT CAPITAL PARTNERS, LLC | 10,430 | $1,043,000 | 0.05% |